Czech National Bank Purchases 1,082 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Czech National Bank grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 7.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,707 shares of the biotechnology company’s stock after acquiring an additional 1,082 shares during the quarter. Czech National Bank’s holdings in Axon Enterprise were worth $9,335,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of AXON. Geode Capital Management LLC grew its holdings in shares of Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP grew its stake in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment bought a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $200,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 over the last quarter. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 2.0 %

AXON stock opened at $579.80 on Wednesday. The stock has a fifty day moving average of $610.03 and a 200-day moving average of $452.93. Axon Enterprise, Inc. has a fifty-two week low of $246.99 and a fifty-two week high of $698.67. The company has a market capitalization of $44.21 billion, a price-to-earnings ratio of 149.82, a PEG ratio of 14.19 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. JMP Securities boosted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $504.92.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.